Personalis, Inc. (PSNL)
NASDAQ: PSNL · IEX Real-Time Price · USD
1.265
+0.015 (1.20%)
At close: Apr 26, 2024, 4:00 PM
1.230
-0.035 (-2.77%)
After-hours: Apr 26, 2024, 4:13 PM EDT
Personalis Revenue
In the year 2023, Personalis had annual revenue of $73.48M with 12.97% growth. Revenue in the quarter ending December 31, 2023 was $19.68M with 17.66% year-over-year growth.
Revenue (ttm)
$73.48M
Revenue Growth
+12.97%
P/S Ratio
0.87
Revenue / Employee
$329,511
Employees
223
Market Cap
63.89M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 73.48M | 8.43M | 12.97% |
Dec 31, 2022 | 65.05M | -20.45M | -23.92% |
Dec 31, 2021 | 85.49M | 6.85M | 8.70% |
Dec 31, 2020 | 78.65M | 13.44M | 20.61% |
Dec 31, 2019 | 65.21M | 27.43M | 72.62% |
Dec 31, 2018 | 37.77M | 28.38M | 302.15% |
Dec 31, 2017 | 9.39M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Precision BioSciences | 48.73M |
Pro-Dex | 48.24M |
Turnstone Biologics | 19.31M |
Hyperfine | 11.03M |
Ikena Oncology | 9.16M |
PSNL News
- 3 days ago - Personalis to Announce First Quarter 2024 Financial Results - Business Wire
- 4 weeks ago - Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference - Business Wire
- 4 weeks ago - Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting - Business Wire
- 4 weeks ago - Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring - Business Wire
- 5 weeks ago - Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Personalis Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 2 months ago - Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 3 months ago - Personalis to Participate at Upcoming Investor Conferences - Business Wire